{"id":"NCT01202578","sponsor":"Integra LifeSciences Corporation","briefTitle":"Evaluation of the Tympanostomy Tube Delivery System","officialTitle":"A Clinical Study of the Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion for Otitis Media","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2010-09","primaryCompletion":"2010-11","completion":"2010-12","firstPosted":"2010-09-16","resultsPosted":"2014-07-11","lastUpdate":"2024-08-06"},"enrollment":53,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Otitis Media With Effusion","Acute Otitis Media"],"interventions":[{"type":"DEVICE","name":"tympanostomy tube","otherNames":[]}],"arms":[{"label":"tympanostomy tube","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the performance and safety of the Tympanostomy Tube Delivery System (TTDS) for chronic otitis media or recurrent acute otitis media.","primaryOutcome":{"measure":"Safety of Tympanostomy Tube (TT) Delivery System","timeFrame":"7 days","effectByArm":[{"arm":"Tympanostomy Tube Placement Using the Tube Delivery System","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":8},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":53},"commonTop":["Tube Lumen Occlusion"]}}